Eduardo Acampado

2.2k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

Eduardo Acampado is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Eduardo Acampado has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Eduardo Acampado's work include Coronary Interventions and Diagnostics (18 papers), Cerebrovascular and Carotid Artery Diseases (7 papers) and Cell Adhesion Molecules Research (4 papers). Eduardo Acampado is often cited by papers focused on Coronary Interventions and Diagnostics (18 papers), Cerebrovascular and Carotid Artery Diseases (7 papers) and Cell Adhesion Molecules Research (4 papers). Eduardo Acampado collaborates with scholars based in United States, Germany and Switzerland. Eduardo Acampado's co-authors include Frank D. Kolodgie, Renu Virmani, Aloke V. Finn, Herman K. Gold, Kristi Skorija, Michael Joner, Qi Cheng, Gaku Nakazawa, Patricia S. Wilson and Jan Harnek and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Eduardo Acampado

19 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

2008 517 citations Michael Joner, Gaku Nakazawa et al. Journal of the American College of Cardiology profile →

Peers

Eduardo Acampado

SURGE

CCM

PRM

RNMI

BIOMA

Greg L. Kałuża United States

Nicolas Chronos United States

Lynn Bailey United States

Adam Groothuis United States

Bruce D. Klugherz United States

Allan R. Camrud United States

Orville Bramwell United States

Rodolfo Staico Brazil

Mathias Vrolix Belgium

Hiroatsu Yokoi Japan

Greg L. Kałuża United States

Eduardo Acampado

1.2k ×0.9

SURGE

546 ×0.6

CCM

610 ×1.2

PRM

352 ×1.2

RNMI

124 ×0.7

BIOMA

Citations per year, relative to Eduardo Acampado Eduardo Acampado (= 1×) peers Greg L. Kałuża

Countries citing papers authored by Eduardo Acampado

Since Specialization

Citations

This map shows the geographic impact of Eduardo Acampado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Acampado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Acampado more than expected).

Fields of papers citing papers by Eduardo Acampado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Acampado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Acampado. The network helps show where Eduardo Acampado may publish in the future.

Co-authorship network of co-authors of Eduardo Acampado

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Acampado. A scholar is included among the top collaborators of Eduardo Acampado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Acampado. Eduardo Acampado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jinnouchi, Hiroyuki, Hiroyoshi Mori, Qi Cheng, et al.. (2019). Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy. EuroIntervention. 15(4). e342–e353. 25 indexed citations

Torii, Sho, Qi Cheng, Hiroyoshi Mori, et al.. (2019). Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents. EuroIntervention. 14(16). 1685–1693. 28 indexed citations

Lipinski, Michael J., Eduardo Acampado, Qi Cheng, et al.. (2019). Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model. EuroIntervention. 14(13). 1420–1427. 26 indexed citations

Jinnouchi, Hiroyuki, Frank D. Kolodgie, Qi Cheng, et al.. (2018). TCT-734 Comparison of Thromboresistance between Everolimus-eluting Fluoropolymer Stent and ELuNIR Ridaforolimus Eluting Coronary StentRidaforolimus-Eluting Stent in an Ex Vivo Swine Shunt Model. Journal of the American College of Cardiology. 72(13). B294–B294. 1 indexed citations

Mori, Hiroyoshi, Qi Cheng, Christoph Lutter, et al.. (2017). Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents. JACC: Cardiovascular Interventions. 10(23). 2375–2387. 29 indexed citations

Waksman, Ron, Michael J. Lipinski, Eduardo Acampado, et al.. (2017). Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds. Circulation Cardiovascular Interventions. 10(8). 82 indexed citations

Koppara, Tobias, Kenichi Sakakura, Erica Pacheco, et al.. (2016). Preclinical evaluation of a novel polyphosphazene surface modified stent. International Journal of Cardiology. 222. 217–225. 24 indexed citations

Otsuka, Fumiyuki, Qi Cheng, Kazuyuki Yahagi, et al.. (2015). Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model. JACC: Cardiovascular Interventions. 8(9). 1248–1260. 86 indexed citations

Vorpahl, Marc, Masataka Nakano, Laura Perkins, et al.. (2014). Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model. EuroIntervention. 10(7). 833–841. 16 indexed citations

10.

Joner, Michael, Gaku Nakazawa, Craig Bonsignore, et al.. (2010). Histopathologic evaluation of nitinol self-expanding stents in an animal model of advanced atherosclerotic lesions. EuroIntervention. 5(6). 737–744. 7 indexed citations

11.

Finn, Aloke V., Michael C. John, Gaku Nakazawa, et al.. (2009). Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor γ Agonists. Circulation Research. 105(10). 1003–1012. 23 indexed citations

12.

Joner, Michael, Gaku Nakazawa, Aloke V. Finn, et al.. (2008). Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents. Journal of the American College of Cardiology. 52(5). 333–342. 517 indexed citations breakdown →

13.

Joner, Michael, Hiroaki Kasukawa, Kristin Steigerwald, et al.. (2008). Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma. Arteriosclerosis Thrombosis and Vascular Biology. 28(11). 1960–1966. 73 indexed citations

14.

Ribichini, Flavio, Michael Joner, Valeria Ferrero, et al.. (2007). Effects of Oral Prednisone After Stenting in a Rabbit Model of Established Atherosclerosis. Journal of the American College of Cardiology. 50(2). 176–185. 50 indexed citations

15.

Joner, Michael, Andrew Farb, Qi Cheng, et al.. (2006). Pioglitazone Inhibits In-Stent Restenosis in Atherosclerotic Rabbits by Targeting Transforming Growth Factor-β and MCP-1. Arteriosclerosis Thrombosis and Vascular Biology. 27(1). 182–189. 63 indexed citations

16.

Finn, Aloke V., Frank D. Kolodgie, Jan Harnek, et al.. (2005). Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents. Circulation. 112(2). 270–278. 448 indexed citations

17.

John, Michael C., Charanjit Khurana, Frank D. Kolodgie, et al.. (2002). A novel preparation of systemic paclitaxel reduces in-stent restenosis in the rabbit. Journal of the American College of Cardiology. 39. 5–5. 1 indexed citations

18.

Kolodgie, Frank D., Michael C. John, Charanjit Khurana, et al.. (2002). Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel. Circulation. 106(10). 1195–1198. 100 indexed citations

19.

Farb, Andrew, Michael C. John, Eduardo Acampado, et al.. (2002). Oral Everolimus Inhibits In-Stent Neointimal Growth. Circulation. 106(18). 2379–2384. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact